Agilon Health (AGL) Cash from Investing Activities (2020 - 2025)
Agilon Health's Cash from Investing Activities history spans 6 years, with the latest figure at $22.6 million for Q4 2025.
- For Q4 2025, Cash from Investing Activities fell 4.6% year-over-year to $22.6 million; the TTM value through Dec 2025 reached $88.6 million, down 36.66%, while the annual FY2025 figure was $88.6 million, 36.66% down from the prior year.
- Cash from Investing Activities reached $22.6 million in Q4 2025 per AGL's latest filing, up from $18.7 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $70.5 million in Q2 2025 to a low of -$296.6 million in Q2 2022.
- Average Cash from Investing Activities over 5 years is -$17.5 million, with a median of -$5.3 million recorded in 2021.
- Peak YoY movement for Cash from Investing Activities: crashed 2944.51% in 2021, then surged 1174.58% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$2.6 million in 2021, then plummeted by 206.19% to -$8.0 million in 2022, then skyrocketed by 72.36% to -$2.2 million in 2023, then soared by 1174.58% to $23.7 million in 2024, then fell by 4.6% to $22.6 million in 2025.
- Per Business Quant, the three most recent readings for AGL's Cash from Investing Activities are $22.6 million (Q4 2025), $18.7 million (Q3 2025), and $70.5 million (Q2 2025).